ACE and chronic kidney disease: While more research in different populations and ethnicities is needed to determine the clinical significance of these findings, the presence of the ACE I/D polymorphism and ACE plasma level in Javanese non-hemodialyzed CKD patients may serve as predictive markers for ASCVD and cardiovascular mortality risk.